These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 15825209

  • 1. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J, Paterniti D, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S.
    Cancer; 2005 May 15; 103(10):1996-2005. PubMed ID: 15825209
    [Abstract] [Full Text] [Related]

  • 2. "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
    Paterniti DA, Melnikow J, Nuovo J, Henderson S, DeGregorio M, Kuppermann M, Nease R.
    Ethn Dis; 2005 May 15; 15(3):365-72. PubMed ID: 16108294
    [Abstract] [Full Text] [Related]

  • 3. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM.
    J Clin Oncol; 2004 Dec 15; 22(24):4951-7. PubMed ID: 15598980
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer risk in primary care: implications for chemoprevention.
    Lewis CL, Kinsinger LS, Harris RP, Schwartz RJ.
    Arch Intern Med; 2004 Sep 27; 164(17):1897-903. PubMed ID: 15451765
    [Abstract] [Full Text] [Related]

  • 5. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM, Christo DK, Lai H, Helzlsouer K.
    Cancer; 2005 Mar 15; 103(6):1147-53. PubMed ID: 15674856
    [Abstract] [Full Text] [Related]

  • 6. Interest in breast cancer chemoprevention among older women.
    Tjia J, Micco E, Armstrong K.
    Breast Cancer Res Treat; 2008 Apr 15; 108(3):435-53. PubMed ID: 17554628
    [Abstract] [Full Text] [Related]

  • 7. Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview.
    Keyzer JF, Melnikow J, Kuppermann M, Birch S, Kuenneth C, Nuovo J, Azari R, Oto-Kent D, Rooney M.
    Ethn Dis; 2005 Apr 15; 15(3):395-406. PubMed ID: 16108298
    [Abstract] [Full Text] [Related]

  • 8. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
    Goldenberg VK, Seewaldt VL, Scott V, Bean GR, Broadwater G, Fabian C, Kimler B, Zalles C, Lipkus IM.
    Cancer Epidemiol Biomarkers Prev; 2007 May 15; 16(5):1032-4. PubMed ID: 17507634
    [Abstract] [Full Text] [Related]

  • 9. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
    Duggan C, Marriott K, Edwards R, Cuzick J.
    J Clin Oncol; 2003 Oct 01; 21(19):3588-93. PubMed ID: 14512389
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
    Rondanina G, Puntoni M, Severi G, Varricchio C, Zunino A, Feroce I, Bonanni B, Decensi A.
    J Clin Oncol; 2008 Mar 20; 26(9):1537-43. PubMed ID: 18349406
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reducing the risk of breast cancer with tamoxifen in women at increased risk.
    Vogel VG.
    J Clin Oncol; 2001 Sep 15; 19(18 Suppl):87S-92S. PubMed ID: 11560980
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.